dexmedetomidine has been researched along with Hemorrhagic Shock in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Katoh, T; Kien, TS; Kobayashi, A; Kobayashi, K; Mimuro, S; Nakajima, Y; Sato, T | 1 |
Li, Y; Lu, Y; Morimatsu, H; Nakamura, R; Omori, E; Sakamoto, R; Shimizu, H; Takahashi, T | 1 |
Huang, Q; Kong, Q; Ming, T; Wu, X; Xia, Z; Yuan, M | 1 |
Huang, CJ; Tsai, PS; Wang, TY; Yang, CH | 1 |
Huang, CJ; Huang, SJ; Tsai, PS | 1 |
5 other study(ies) available for dexmedetomidine and Hemorrhagic Shock
Article | Year |
---|---|
Dexmedetomidine suppresses serum syndecan-1 elevation and improves survival in a rat hemorrhagic shock model.
Topics: Animals; Dexmedetomidine; Disease Models, Animal; Inflammation; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Syndecan-1; Tumor Necrosis Factor-alpha | 2022 |
Dexmedetomidine improves acute lung injury by activating autophagy in a rat hemorrhagic shock and resuscitation model.
Topics: Acute Lung Injury; Animals; Autophagy; Beclin-1; Dexmedetomidine; Lung; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2023 |
Dexmedetomidine alleviates blunt chest trauma and hemorrhagic shock‑resuscitation‑induced acute lung injury through inhibiting the NLRP3 inflammasome.
Topics: Acute Lung Injury; Animals; Cytokines; Dexmedetomidine; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; L-Lactate Dehydrogenase; Male; Malondialdehyde; NLR Family, Pyrin Domain-Containing 3 Protein; Peroxidase; Rats; Resuscitation; Shock, Hemorrhagic; Signal Transduction; Superoxide Dismutase; Thoracic Injuries; Wounds, Nonpenetrating | 2020 |
Dexmedetomidine-ketamine combination mitigates acute lung injury in haemorrhagic shock rats.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Blood Pressure; Bronchoalveolar Lavage Fluid; Dexmedetomidine; Drug Combinations; Inflammation Mediators; Infusions, Intravenous; Ketamine; Lung; Macrophages, Alveolar; Male; Organ Size; Peroxidase; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Up-Regulation | 2009 |
Dexmedetomidine-ketamine combination mitigates pulmonary type-2 cationic amino acid transporter isozymes upregulation in hemorrhagic shock rats.
Topics: Analgesics, Non-Narcotic; Anesthetics, Dissociative; Animals; Cationic Amino Acid Transporter 2; Dexmedetomidine; Drug Combinations; Ketamine; Lung; Male; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic; Up-Regulation | 2010 |